Category Archives: Drug Safety

Boehringer Ingelheim Announces Cooperation with HISOAR in China

It is poetic that following the close of the Olympics in Beijing – an event that went very well in spite of all the worries leading up to it – that Boehringer Ingelheim announces a cooperation deal with a Chinese … Continue reading

Posted in Drug Safety, Pharma Industry Image | Comments Off

FDA Posts New Education Vids on Safety Alerts

The FDA posted two new vids to its YouTube account.  Much more than in the past, these are very timely, having only been issued this week and the vids are up.  Good job FDA!  The first involves the fact that … Continue reading

Posted in Drug Safety, New and Social Media | Comments Off

Warning! Warning! Warning! (Yawn)

Pursuant to the posting earlier this week which noted the rate of drug safety alerts out of the FDA, there also this week was a story published at that raises the very valid question whether or not patients and … Continue reading

Posted in Drug Safety, FDA Policy | Comments Off

Returning a Product to Market After it is Tossed

The FDA announced on Friday that the drug Zelnorm, manufactured by Novartis, would be returning to market for the treatment of women with irritable bowel syndrome (IBS) for certain patients only. "These patients must meet strict criteria and have no … Continue reading

Posted in Drug Safety, Risk Management | 1 Comment

Product Specific Advisory Committee Meeting s

Tomorrow’s Federal Register is scheduled to carry a notice of a joint meeting of the Cardiovascular and Renal Drugs Advisory Committee with the Drug Safety and Risk Management Advisory Committee to be held on September 11, 2007.  The committees will … Continue reading

Posted in Drug Safety | Comments Off